MedTrace Logo

A Study to Evaluate the Effect of SlimBiotics L. Fermentum K8 Postbiotic on Weight Management and Metabolic Health Outcomes

NCT05912699 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-06-22

No results posted yet for this study

Summary

This study is to evaluate the efficacy of a postbiotic supplement on weight management and metabolic health. This study will be conducted as a hybrid trial consisting of both in-person visits and virtual assessments. Two groups will be included: the intervention (SlimBiotics postbiotic) and placebo.

The SlimBiotics postbiotic formula is the first plant-based postbiotic targeting weight management and metabolic health. Other competing postbiotics are isolated from humans (feces) but the strains in SlimBiotics were isolated from a fermented plant (millet porridge cereal)

This product contains L. fermentum K8 Postbiotic.

Conditions

  • Metabolic Health
  • Weight Loss
  • Stress
  • Well-Being, Psychological
  • Sleep
  • Healthy Eating

Interventions

OTHER

Slimbiotics Postbiotic

SlimBiotics postbiotic formula contains the following ingredients: * Heat-inactivated L. fermentum K8 Postbiotic. * Microcrystalline cellulose.

OTHER

Placebo

The placebo capsules contain microcrystalline cellulose only.

Sponsors & Collaborators

  • Citruslabs

    collaborator INDUSTRY

  • Slimbiotics

    lead UNKNOWN

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2023-09-23
Completion
2023-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05912699 on ClinicalTrials.gov